Cargando…
Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients
Lithium is the gold standard therapy for Bipolar Disorder (BD) but its effectiveness differs widely between individuals. The molecular mechanisms underlying treatment response heterogeneity are not well understood, and personalized treatment in BD remains elusive. Genetic analyses of the lithium tre...
Ejemplares similares
-
Correction: Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients
por: Schubert, Klaus Oliver, et al.
Publicado: (2022) -
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders
por: Le Clerc, Sigrid, et al.
Publicado: (2021) -
Immunogenetics of lithium response and psychiatric phenotypes in patients with bipolar disorder
por: Herrera-Rivero, Marisol, et al.
Publicado: (2023) -
Lithium Response in Bipolar Disorder is Associated with Focal Adhesion and PI3K-Akt Networks: A Multi-omics Replication Study
por: Kelsoe, John, et al.
Publicado: (2023) -
Long-Term Lithium Therapy: Side Effects and Interactions
por: Ferensztajn-Rochowiak, Ewa, et al.
Publicado: (2023)